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Abstract
Pain is prevalent, burdensome, and undertreated in individuals with cancer across the disease 
trajectory. Providing patients and family caregivers psychosocial support and education to manage 
cancer pain is a core component of quality care that can result in significant clinical benefit. In this 
review, we (1) outline an approach for developing and assessing the effectiveness of education 
programs for adults with cancer pain; (2) discuss considerations for tailoring programs to the 
needs of diverse populations and those with limited health literacy skills; (3) describe the resource 
needs and costs of developing a program; and (4) highlight innovative approaches to cancer pain 
education. We conclude with recommendations for future research and the next generation of 
educational interventions.
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Introduction
Cancer-related pain is prevalent across the cancer trajectory. A review of 52 studies found 
that pain affects 59% of cancer patients on anticancer treatment, 64% of patients coping with 
advanced-stage or metastatic disease, and 33% of survivors post-treatment [1]. For more 
than 30% of cancer patients, pain was moderate to severe in intensity [1, 2]. Although there 
are guidelines regarding the management of cancer pain [3**], pain control among cancer 
patients and survivors is suboptimal, with as many as 50% undertreated for their pain [4] 
and greater than 70% of advanced cancer patients expected to have unrelieved pain as a 
symptom at the end of life [5].
Reducing the pain and suffering of cancer patients is essential to delivering quality care. 
Pain experienced by adults with cancer affects quality of life [6], physical functioning [6–8], 
roles and social functioning [6], concentration [7*], and mental health [8]. Pain often co-
occurs with additional symptoms, such as fatigue, sleep disturbance, loss of appetite, and 
anxiety [6, 7*, 9, 10]. If pain is accompanied by depression, its deleterious effects on quality 
of life and disability are amplified [11]. Moreover, pain in cancer patients is associated with 
high costs and extensive utilization of health care [12, 13]. For patients receiving care in 
outpatient clinics, monthly costs (in 2011 US dollars) were, on average, $107–$120 for 
analgesics and medical visits and $82 for indirect costs, including over-the-counter 
medications, complementary medicine, and counseling. Including the costs of 
hospitalization, which occurred in about 8% of patients, the average expenditure was $1,209 
per month per patient [12]. Cancer patients who report pain also report financial difficulties 
[6].
The effective management of cancer pain includes pharmacological and non-
pharmacological approaches [3**, 5, 14]. Nociceptive pain, resulting from tissue injury or 
impending injury, is typically localized, and is responsive to opiate medications. 
Neuropathic pain, resulting from injury or malfunction of pain nerves or the central nervous 
system, often due to chemotherapy treatment, tends to be chronic and does not respond well 
to opioids. It may be partially ameliorated by anti-convulsant or anti-depressant medications. 
In the treatment of pain, one should be cognizant of the complexity of the pain experience 
for cancer patients and survivors. This complexity rests in the combination of anatomic and 
physiologic disruptions that drive nociceptive and neuropathic pain syndromes and in the 
interplay of educational, psychological, social, economic, and spiritual factors that frame the 
pain experience and contribute to “total pain.” For this reason, education and psychosocial 
support for cancer patients and their families have become a standard component of cancer 
care [3**]. Three recent meta-analyses have demonstrated efficacy of educational and/or 
psychosocial interventions on various outcomes, including decreasing pain intensity [15**, 
16**, 17**]. Thus, health care providers need a framework for developing education 
programs relating to cancer pain.
In this report, education programs for cancer pain are defined as “information, behavioral 
instructions, and advice in relation to management of cancer pain” [15**]. To be useful for 
healthcare providers developing and/or delivering education programs for cancer pain, we 
first describe the essential components of a program and models from the literature. We then 
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provide practical guidance for developing a program and for assessing how well it works, 
and describe well-validated assessment tools that may be used for this purpose. We conclude 
with recommendations for advancing the science of education programs for cancer pain.
Developing an Education Program for Cancer Pain
Essential Components
A recent analysis of major evidence-based clinical practice guidelines for cancer-related 
pain concluded that educational interventions need to: (1) address barriers to pain 
management by dispelling myths/misconceptions about pain and pain management, 
particularly with regard to addiction and tolerance to pain medication; (2) promote 
involvement of patients and family caregivers in education about pain and its management; 
and (3) use appropriate teaching materials, particularly for patients with low-literacy and for 
whom English is a second language [14]. Similarly, in the most extensive systematic review 
and meta-analysis of cancer pain educational interventions to date, Cummings et al. 
recommended that programs focus on knowledge, skills, and attitudes about pain and pain 
management and use pre-constructed education materials [16**]. Efficacious patient 
education programs have also emphasized communicating with healthcare providers about 
pain and enhancing pain-related coping skills (e.g., self-monitoring, problem solving, and 
changing maladaptive cognitions about pain) [18*, 19*, 20, 21*, 22, 23]. Moreover, in 
recognition of the complexity of the pain experience in cancer patients, Cummings et al. 
[16**] recommended that programs be developed and delivered by a multidisciplinary team 
of content experts.
Most of the effective educational interventions for cancer pain consist of individualized, 
face-to-face coaching sessions, usually 30–60 minutes in length, and sometimes involving a 
video or digital videodisc (DVD) presentation with written materials or booklets [16**]. 
Table 1 describes some of the emerging programs for cancer patients that have been 
effective and may offer ideas for those who are designing a new cancer patient education 
program.
In summary, the essential components of an educational program for cancer pain are 
delineated in guidelines for management of cancer pain,[3**] and interventions related to 
these guidelines have improved pain-related outcomes. Below we provide guidance on 
developing educational programs for adults with cancer that are shaped by characteristics of 
the disease, the patient, and the context of each patient’s life.
Designing Programs across the Cancer Continuum
Newly diagnosed or patients in treatment—The varying experiences of patients 
across the cancer continuum make it necessary to tailor cancer pain education programs to 
the phase of survivorship. For newly diagnosed patients, the ability to process and retain 
information is usually compromised [24], and many patients struggle to make treatment 
decisions [25]. From the patient’s perspective, treatment decisions may take priority over 
management of pain and other symptoms. Patients and family members may be reluctant to 
mention pain to their physicians because of concern that it will distract the physician from 
the treatment of the cancer [26, 27]. Therefore, pain education programs at this phase should 
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allow for opportunities for repetition of information and offer reassurance that treatment for 
cancer and optimal symptom management can coexist. Providers must also be mindful that 
preferences for information and level of involvement in making medical decisions are 
dynamic and thus should be continually assessed and honored [28].
Patients who have completed primary treatment—Unlike patients in treatment who 
have regular contact with healthcare providers, post-treatment cancer survivors may have 
fewer opportunities to present their concerns about pain and/or participate in education 
programs for cancer pain. Although some oncology clinics are starting to provide post-
treatment survivors with “survivorship care plans” (i.e., a summary of treatments received, 
surveillance plans, and recommendations for preventing/addressing late effects and chronic 
effects of cancer, such as pain) [29, 30], many survivors do not receive such care plans and 
are completing treatment without an adequate understanding of how to manage symptoms, 
and when to seek care. Moreover, it may be unclear who is responsible for pain 
management, placing cancer survivors at risk for poor control of pain [29].
During this phase of survivorship, pain symptoms may raise concerns about recurrence [31, 
32] which can be distressing and a potential barrier to seeking care. Once primary treatment 
is completed, pain education programs should address the patient’s understanding of chronic 
pain symptoms and provide guidance on when it may be necessary to access care. Because 
post-treatment survivors may not have frequent healthcare visits, innovative ways to deliver 
education programs for cancer pain may be needed. A promising approach used by Kroenke 
and colleagues (2010; see Table 1) improved pain and depression outcomes in adults with 
cancer using automated home-based symptom monitoring coupled with telephonic education 
and symptom management from a nurse care manager [33*].
Near the End of Life—More than 403,000 cancer patients are expected to die with 
unrelieved pain in the United States in 2012 [5]. Patients with advanced cancer have been 
shown to benefit from educational interventions in recent clinical trials [21*, 34*]. 
Interventions in this group need to be of low burden and demonstrate effects quickly [15**]. 
Educational interventions in the setting of advanced cancer may need to address analgesic 
adverse effects, which may increase as patients become frail and death draws near. Patients 
may benefit from early referrals to a palliative care service for pain and symptom 
management, as well as from having health care providers who can skillfully address the 
effects of psychosocial issues (e.g. existential issues, fear of dying, need for autonomy and 
control) on symptom management and remain cognizant of the shifting treatment goals of 
the patient [35].
Involving Family Members in the Education Program for Pain
Family members are frequently involved in helping to manage cancer pain (e.g., by 
discussing pain management with the care recipient and healthcare providers, by 
administering pain medications) [36]. More than 40% of caregivers (most of whom were 
family members) report receiving no instruction in managing their loved one’s pain [37], 
and many report feeling hesitant to disclose the patient’s pain to the oncologist. Family 
caregivers who were hesitant to report pain also reported fear of distracting the oncologist 
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from treating the cancer, fear of addiction to opioids, and fatalism in regard to pain relief 
[38].
There is now an opportunity to shift the approach to cancer pain education, which has 
traditionally focused on the individual with pain, by adopting a “family-centered” approach, 
as highlighted in a recent review of guidelines for management of cancer pain [14]. This 
approach recognizes that family members are involved in care and are participants in 
decisions regarding the patient. Family-centered care respects the culture, values, beliefs, 
perspectives, and choices of the family members who are instrumental to the care of the 
patient.
Developing Programs for Those with Limited Health Literacy Skills
Only 12% of American adults have proficient health literacy skills [39]. Education programs 
for cancer pain should engage patients with diverse health literacy skills. Health literacy is 
people’s “knowledge, motivation and competencies to access, understand, appraise, and 
apply health information in order to make judgments and make decisions in everyday life 
concerning health care, disease prevention and health promotion to maintain or improve 
quality of life during the life course” [40]. Some views include the ability of individuals to 
orally communicate about health [41], the latter particularly relevant as inadequate 
communication with health care providers is a common barrier to care for cancer patients 
[42].
Recommendations are available for assessing health literacy and designing educational 
materials to meet the needs of individuals with diverse health literacy skills [43–47]. 
Strategies for addressing literacy through verbal communication and printed materials 
include use of conversational and peer language and use of the active voice. Information 
should be limited to what is needed at the time. The focus should be on specific steps and 
actions the patient can take rather than on presenting facts and statistics.
To assure that patients of all literacy levels benefit, educational materials should be pretested 
with the intended audience. Pre-testing provides information regarding the acceptability of 
the materials and allows the developer to assess comprehension, determine the degree to 
which patients believe the materials have relevance for them, evaluate cultural 
considerations, establish if there is enough information to accomplish the suggested 
behaviors, and determine if it motivates them to act [48].
Developing Cancer Pain Education Programs for Diverse Populations
It is important to tailor pain education programs to serve cancer patients of all backgrounds 
and across the cancer continuum. Table 2 provides some practical approaches to address 
typical challenges faced by providers who care for adults with cancer-related pain. Below 
we provide some additional considerations for working with two populations: (1) older 
cancer survivors, and (2) minority populations.
Older Cancer Survivors—Special consideration may be needed to deliver education 
programs on cancer pain to older cancer survivors. Adults with metastatic cancer who are 
age 70 years or older are 2.4 times more likely than younger patients to receive inadequate 
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pain management [49]. Further, older age appears to influence attitudes towards pain and 
analgesics. Factors such as poorer knowledge about taking analgesics, reluctance to 
communicate with medical staff, poorer performance status, and being more likely to live 
alone suggest that older patients require more support in the management of their cancer 
pain and education tailored to their needs [50]. It is also likely that older cancer survivors are 
also managing multiple comorbidities, including illnesses associated with their own 
constellation of pain symptoms.
Minority Populations—Racial/ethnic disparities across the pain continuum are pervasive. 
Black, Asian, and Hispanic cancer patients are undertreated for pain [51, 52]. Black cancer 
patients have greater pain intensity, pain interference, and disability [6, 53] and in contrast to 
white cancer patients, black cancer survivors often do not experience pain relief even after 
consultation with supportive care [54].
Barriers to pain management type, ranking, and number may differ for demographic groups 
[52]. Stoicism is apparent in Hispanic and African American cancer patients, suggesting 
that, for some demographic groups, a report of lack of pain does not necessarily indicate an 
absence of pain [55]. Similarly, lack of reporting pain is associated with stoicism, fatalism, 
and concern that pain will be a burden to family among Chinese American cancer patients 
[56]. Culture also influences the patient-provider relationship. In some cultures, for example, 
the physician raises the important issues and introduction of a different topic (e.g., pain) 
would suggest that the patient was questioning the clinician’s judgment on what was 
important [57].
To ensure that programs and materials reflect cultural considerations, it is important to 
involve the patient population and/or relevant stakeholders (e.g., caregivers) in program 
development. Lasch and colleagues [58] engaged minorities in the development of 
multicultural education materials for cancer pain and gleaned many insights. For example, 
Latino focus group participants indicated that they would be more likely to comply with a 
treatment that is described as “important” versus one that is framed as “helpful.” Latino 
participants also shared that concepts such as “control and prevention” were less 
understandable to Latinos. Using phrases such as “keep it from coming back,” “make 
better,” or “help this” would be more effective [58]. In sum, delivering care to diverse 
populations requires careful exploration of the pain experience, including cultural 
considerations, throughout the cancer journey.
Assessing the Effectiveness of an Education Program for Cancer Pain
All patients with cancer should be screened for pain during the initial evaluation, at regular 
follow-up intervals, and whenever new therapy is initiated [3**]. Because health care 
providers often underestimate patients’ pain severity [57], the standard of care for 
measurement is patient self-report. Suggestions are offered in the National Comprehensive 
Cancer Network (NCCN) Adult Cancer Pain Clinical Practice Guidelines for pain 
assessment in those unable to verbally report pain [3**]. Consistent with the current 
emphasis on measurement-based care [59], we suggest a brief and targeted assessment using 
standardized measures to facilitate personalized care, track patient progress, guide treatment 
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adjustments, and evaluate how well a pain education program is working. The measures we 
suggest below are brief; can be scored in less than one minute; are available at no cost for 
health care providers; and are valid and responsive to intervention effects. Consistent with 
expert consensus regarding caring for or investigating pain [60, 61], we recommend serial 
assessment of: (1) pain severity and functional interference, and (2) patient ratings of global 
improvement and satisfaction.
Brief Pain Inventory
The Brief Pain Inventory (BPI) was developed to assess cancer-related pain and has also 
been validated for use in primary care and other clinical populations [62–65]. The BPI 
includes subscales for severity and interference. Four items assess pain severity (currently, 
least, worst, and average) during the past week on scales from 0 = no pain to 10 = pain as 
bad as you can imagine. The severity subscale is scored as the mean of the 4 items. An 
additional seven items assess pain-related functional interference across different domains 
(i.e., general activity, mood, walking, normal work, relations with other people, sleep, and 
enjoyment of life) rated from 0 = does not interfere to 10 = interferes completely. The 
interference subscale is scored as the mean of the seven interference items. The BPI has 
demonstrated internal consistency (Cronbach’s alpha = 0.77–0.91), has been validated in 
more than 36 languages, and is responsive to both pharmacologic and behavioral pain 
interventions [62]. The measure is available online at: http://prc.coh.org/pdf/BPI%20Short
%20Version.pdf
If a shorter measure is needed, a three-item version of the BPI has shown strong initial 
psychometric performance [66]. This abbreviated measure, known as the PEG, includes one 
severity item (average Pain) and two functional interference items (interference with 
Enjoyment of life and General activity). For each scale, the total score is the average of the 
items.
Patient-Reported Improvement
A retrospective global rating of improvement provides a patient-centered approach to 
assessing change that is clinically meaningful [67]. Most global ratings are based on the 
Patient Global Impression of Change scale (PGIC) [68], which is advocated for use by the 
Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) 
committee [60]. The PGIC is a single-item rating by patients of their improvement with 
treatment on a 7-point scale that ranges from 1 = very much improved to 7 = very much 
worse. A related approach that has been used in a recent cancer pain and depression clinical 
trial involves asking, “Overall, since starting the program, would you say that your pain is 
worse, about the same, or better?” Those rating their pain as better are then asked if their 
pain is a little better, somewhat better, moderately better, a lot better, or completely better 
[33*].
If discordant results emerge between the global rating and the BPI or PEG, this provides 
clinically useful information. For example, the BPI/PEG may suggest improvement in pain 
whereas the patient globally assesses his or her status as about the same. If this occurs, the 
provider is encouraged to explore reasons for the discrepancy from a biopsychosocial 
Martin et al. Page 7
Curr Pain Headache Rep. Author manuscript; available in PMC 2015 April 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
framework (e.g., comorbid physical or psychological conditions). Although retrospective 
global ratings are subject to varying degrees of recall bias depending upon length of the 
recall period, current severity of symptoms, and other patient- and disease-specific 
confounding factors,[69] they have face validity, are generally more sensitive than serial 
symptom assessments, and correlate strongly with patient satisfaction with treatment [67]. 
Notably, satisfaction with cancer pain management operated as a significant mediator 
between barriers to analgesic use and analgesic adherence in a recent randomized controlled 
trial [70].
Additional Measures Of Interest
Patients with pain often have other symptoms (e.g., depression, anxiety, constipation, 
nausea, fatigue, sleep disturbance) that need to be controlled to facilitate optimal pain 
control [3**]. Brief, validated, and no-cost measures to assess depression and anxiety in 
adults with cancer are the 9-item Patient Health Questionnaire depression scale (PHQ-9)[71] 
and the 7-item Generalized Anxiety Disorder anxiety scale (GAD-7) [72]. Both measures 
ask patients to rate how often they have been bothered over the past 2 weeks by various 
problems on a 4-point Likert scale from 0 = not at all to 3 = nearly every day. Each is 
available in two-item versions, and together they make up the brief PHQ-4, which is valid 
for use in medical populations [73]. The PHQ-9, GAD-7, and PHQ-4 are validated in 
Spanish and numerous other languages. These measures and the scoring instructions are 
available at no cost at: http://www.phqscreeners.com/.
If reducing barriers to pain management is the focus of a pain education intervention, an 
outcome measure that may be used is the Barriers Questionnaire (BQ). Although originally 
developed as a 27-item measure [74], a 13-item version (BQ-13) has recently been shown to 
be valid, reliable, sensitive to change, and psychometrically equivalent to the longer version 
for adults with cancer [75]. The BQ-13 includes seven items that measure barriers related to 
pain management and six items related to the side effects for analgesics. Patients are asked 
to respond to each item according to a six-point Likert scale from 0 = do not agree at all to 5 
= agree very much.
A recent examination of additional outcomes that patients with chronic pain consider 
important to measure includes enjoyment of life, well-being, fatigue, and sleep disturbance 
[76]. Providers may consider assessing these outcomes in evaluating how well cancer-
related pain educational programs are working.
Considerations of the Cost of a Pain Education Program
A pain education program will vary in resource needs and cost depending on the intensity of 
the program, the size and type of the patient population (in treatment, in survivorship, at end 
of life) and the delivery channel. Face-to-face interventions will include one or more full 
time positions for oncology nurses or other nurse-physician specialists to conduct in-person 
education sessions and follow-up phone sessions with pain assessments. However, this 
personnel cost may be lower if lay health workers are employed instead (Table 1) [19*]. In a 
study comparing psychologist-led and lay-led interventions to reduce back pain, the lay-led 
intervention cost $100 per patient served and the psychologist-led intervention cost $210 per 
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patient; however, the psychologist-led intervention also had slightly better outcomes [77]. 
The cost of the program will include phone charges and other costs of space, computers, and 
educational materials. Cost of shipping will need to be considered if materials need to be 
mailed to patients, particularly if in-person sessions are not part of the program or for 
survivors who may not visit the provider on a regular basis. No-cost cancer pain education 
materials (e.g., booklets, DVDs) are available through the National Cancer Institute (NCI) 
[78] and American Cancer Society (ACS); [79] however, if program developers prefer to 
create materials specific to their program, production costs will need to be considered. 
Interventions that involve technology such as MP3 players [80] will need to consider the 
cost of such technology and associated programming.
During program development, resources may be needed to assure that the intervention is 
appropriately tailored to the target population. Thus, time of multidisciplinary content 
experts will be necessary to develop the curriculum, and to gather, select, and modify 
materials as needed. In the case where focus groups are utilized to verify the specific 
education needs of a population, costs of focus group moderators, incentives for participants, 
and analysis of the data must be considered. Finally, personnel time will be needed to create 
databases or filing systems to keep track of patients, encounters, and pain assessment results. 
Technology may provide a way to capture information in a streamlined way with minimal 
burden on the healthcare team or the patient. For example, using a tablet connected to a 
wireless network, cancer patients can complete a symptom severity screening scale as they 
wait for their appointment. A report reflecting current symptoms as well as symptoms from 
previous visits is generated and provided to the clinician and included in the patient’s 
medical record. This approach was received well by both physicians and patients in two 
recent trials [81, 82].
Conclusion
Based on two recent meta-analyses [15**, 16**], findings from other emergent studies [19*, 
21*, 22, 33*, 83*] and clinical practice guidelines [3**], cancer pain educational 
interventions should be an essential part of daily clinical practice. Further research is needed 
to identify patients who may or may not obtain the most benefit [15**], determine the 
influence of factors such as provider expertise and patient learning styles [84], establish the 
optimum timing of education interventions in relation to pain intensity [15**], maximize 
cost-effectiveness in the implementation of interventions, evaluate use of multi-media 
approaches, and identify the mechanisms of action in improvement in cancer pain and 
coping due to educational interventions. Research is also needed to establish how best to 
involve family members in education programs for cancer pain. Involving caregivers in 
educational interventions has had mixed effects in past clinical trials [23, 85]. Understanding 
the reach of programs (e.g., do programs appeal to the intended patient population) is also 
important. To date, whites, females, and those recruited from medical facilities comprise the 
majority of program participants [17**].
Our review provides guidance regarding the development and delivery of educational 
programs to manage cancer pain. Health care providers are also encouraged to acquire and 
use available evidence-based clinical practice guidelines, such as those from the NCCN 
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[3**], which outline the core messages to be conveyed to patients and family caregivers 
about cancer pain. Educational materials consistent with these guidelines (e.g., booklets, 
DVDs, web-based information) are available as previously mentioned, through the ACS and 
NCI and can be readily incorporated into the design of any developing program. In using 
these materials, providers should remain mindful of their patient population and consider 
tailoring or adding supplemental material to optimize relevance and effectiveness in diverse 
populations. Providing ongoing assessment and education is the standard of care in the 
treatment of cancer-related pain [3**], and with the incorporation of topics reviewed here, 
health care providers have the potential to greatly reduce pain and suffering and improve 
quality of life in their cancer patients.
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g 
gr
ou
p 
co
m
pa
re
d 
to
 e
du
ca
tio
n 
or
 u
su
al
 c
ar
e 
gr
ou
ps
Sm
ith
 e
t a
l.,
 2
01
0 
[2
2]
•
B
re
as
t c
an
ce
r p
at
ie
nt
s w
ith
 
pe
rs
ist
en
t a
nd
 m
od
er
at
e 
pa
in
•
N
 =
 8
9
•
Co
m
pa
re
d 
a 
sin
gl
e 
30
-m
in
ut
e 
pa
in
 e
du
ca
tio
n/
co
m
m
un
ic
at
io
n 
sk
ill
s 
tr
ai
ni
ng
 se
ss
io
n 
(i.
e.,
 m
yth
s/m
isc
on
ce
pti
on
s a
bo
ut 
pa
in 
an
d a
na
lge
sic
s; 
co
m
m
u
n
ic
at
in
g 
w
ith
 h
ea
lth
ca
re
 p
ro
vi
de
rs
 a
bo
ut
 o
ne
’s
 p
ai
n 
an
d 
do
in
g 
in
-s
es
sio
n 
ro
le
 p
la
ys
; m
on
ito
rin
g 
pa
in
 a
nd
 in
-s
es
sio
n 
pr
ac
tic
e 
us
in
g 
a 
pa
in
 d
ia
ry
) t
o a
tte
nti
on
 co
ntr
ol
•
↓ P
ai
n 
ba
rri
er
s
•
N
o 
sig
ni
fic
an
t e
ffe
ct
 o
n 
pa
in
 re
lie
f, 
ad
eq
ua
cy
 o
f p
ai
n 
m
an
ag
em
en
t, 
di
str
es
s, 
or
 q
ua
lit
y 
of
 li
fe
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R
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 T
ri
al
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R
ef
er
en
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Pa
rt
ic
ip
an
ts
In
te
rv
en
tio
n
Fi
nd
in
gs
•
D
el
iv
er
ed
 b
y 
in
te
rv
en
tio
ni
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 w
ith
 tr
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ni
ng
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sy
ch
ol
og
y,
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ub
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he
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lth
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